info@aurevixpeptides.com
Illustrative vial: SemaxSemax

Illustrative presentation

INFORMATIONAL REFERENCE

Semax

Semax is investigated for neurotrophic signaling, including BDNF and TrkB. These pathways are relevant to neuronal adaptation; the cited preclinical findings do not establish better human memory or concentration.

Research focus & potential applications

Neurotrophic pathways
Neuronal adaptation

What the research shows

Explore the selected studies, their findings and their limits.

Read the findings & sourcesPreclinical evidence

A rat hippocampus study reported changes in BDNF and TrkB signaling and performance in a conditioned behavioral task after Semax. BDNF is involved in neuronal adaptation. These observations are a basis for mechanistic research; they do not establish a reliable improvement in human memory, attention or recovery after stroke.

For more information, contact info@aurevixpeptides.com.

Editorial review: September 23, 2026